Ertugliflozin: A New SGLT2 Inhibitor for Type 2 Diabetes

Prescriber - United Kingdom
doi 10.1002/psb.1798
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley